CSS
LNAI

Cubist Systematic Strategies’s Lunai Bioworks LNAI Stock Holding History

Cubist Systematic Strategies’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-321
Closed -$7.42K – 3466
2025
Q2 		$7.42K Buy
+321
New +$8.96K ﹤0.01% 2847
2024
Q2 		– Sell
-250
Closed -$53K – 3841
2024
Q1 		$53K Buy
+250
New +$67.4K ﹤0.01% 3373
2023
Q4 		– Sell
-136
Closed -$48.7K – 4015
2023
Q3 		$48.7K Buy
+136
New +$20.7K ﹤0.01% 3032
2022
Q3 		– Sell
-325
Closed -$50K – 4674
2022
Q2 		$50K Buy
325
+164
+102% +$75K ﹤0.01% 4095
2022
Q1 		$106K Sell
161
-259
-62% -$138K ﹤0.01% 3226
2021
Q4 		$245K Buy
420
+29
+7% +$21.1K ﹤0.01% 2933
2021
Q3 		$211K Buy
+391
New +$191K ﹤0.01% 2560

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cubist Systematic Strategies's LNAI Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 321 shares — an estimated $7.42K sold.

Cubist Systematic Strategies first reported a position in LNAI in Q3 2021 and held it in 7 quarters. The position peaked at $245K in Q4 2021. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 321 Lunai Bioworks shares in Q3 2025, an estimated $7.42K.
  • Cubist Systematic Strategies first reported a position in Lunai Bioworks in Q3 2021 and held it in 7 quarters.
  • Cubist Systematic Strategies's Lunai Bioworks position peaked at $245K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.